R D Competitive Intelligence
Resume:
JEANNE ANDRADE
**** ****** ****, ********* ** ***47
*******.******@*****.***
PROFESSIONAL EXPERIENCE
In 2016, I took a sabbatical to help family, and I am now returning to the work force. Teva Pharmaceuticals 2014- 2016
Director of Generic Pipeline and Portfolio Management Led product screening and selection process for generic drug opportunities in the US market. Collaborated with R&D, operation, Legal, marketing and BD units. Portfolio Segments Expert: Track and analyze trends (markets, technology, etc.) and communicate implications, opportunities or threats to the organization or in relevant business segments. In coordination with the Market Research team, conduct analyses of innovative and potential new generic products based on clinical and industry intelligence. Coordinate cross-functional reviews to leverage expertise across the organization. Facilitated product discussions to ensure timely decisions and recommendations including R&D allocation and forecasting the value of products based on different scenarios.
Led product strategy for specific business segments, defining submission and launch timelines, established plans to mitigate risks. Shire/Takeda
Director Competitive Intelligence
Business Development 2012-2014
Conducted due diligence of early and late-stage opportunities across therapy areas including Inflammatory Bowel Disease, CNS, Ophthalmology, and Oncology.
Collaborated with R&D, Commercial, Regulatory, Legal, and medical teams in providing commercial and scientific intelligence in addition to evaluation of potential asset delivering integrated analysis for decision making with the goal of optimizing potential assets for Shire Business.
Analyzed markets and business segments for trends, competitive threats, providing insight for fact-based decision making on product and company strategy.
Provided disease area leadership enabling decision making by providing an independent externally driven view and recommendations on key decisions and drivers of performance.
Pfizer Inc. 2010-2012
Global Research &Development
Worldwide Regulatory Strategy
Director Business Impact Global Regulatory Intelligence Scope of responsibilities included providing Regulatory Competitive Intelligence and Business Impact Analysis support to Primary Care Business Units. Collaborate with Business unit teams by therapy area in regulatory issues, advisory committee preparation, strategic development alternatives as well as changes in the regulatory environments. Manage and support regulatory guidance documents for organization call for comments. Comprehensive Analysis of business issues among other development projects such as life cycle management, orphan drug strategies, and global regulatory strategies both short and long term. Team member for submission for pipeline/portfolio management initiatives. Provided assessment of regulatory and scientific risks for development projects.
Supported organizational decision making through transparency and collaboration with teams to identify current and future regulatory or business needs, hurdles, providing insight into alternative scenarios and potential planning designs in support of team and organizational goals.
Developed global and regional analysis processes on competitor development, regulatory issues, and clinical trial results and presented results to senior management and teams for selection. Advocate and executor of Pfizer “one voice” in the management of the comments for Global Health Authority Draft Guidance’s. DAIICHI SANKYO Pharmaceuticals 2005– 2010
Director Scientific and Competitive Intelligence
Scope of responsibilities included providing Competitive Intelligence and Market Research support to Integrated Project Teams (IPT) working in oncology, and cardiovascular diseases. Worked with teams to develop disease & product profiles, assess strategic development alternatives. Supported teams in the process of identification, selection, and prioritization of product indications. Provided teams with timely and relevant competitive intelligence, and unbiased recommendations. Member of portfolio management teams developing best-in-class portfolio methodologies for assessing and mitigating technical and scientific risks of development projects. Led project teams in the assessment of development and commercial both launch and inline programs and prioritization for portfolio reviews. As member of due diligence teams for oncology and diabetes, conducted thorough risk assessments, established critical success factors, and provided the licensing teams with relevant competitive intelligence. Worked with due diligence teams to prepare recommendations for senior management.
Provided insights for oncology teams and project teams from pre-IND to Phase III to meet or exceed portfolio goals and to enable successful global development and commercialization of molecules. Designed and recommended product positioning options, pricing and reimbursement analysis, patent strategies, and early commercial strategies.
EDUCATION
Master of Science - Drexel University School of Medicine - Philadelphia, PA. 2010 Bachelor of Arts - Texas State University, San Marcos, TX. 1989 AFFILIATIONS
Adjunct Professor at Drexel University Medical School (Graduate Program-Clinical Research Operations/Management) Board Member University of Texas Arlington Market Research Graduate-Post Graduate Studies Board Member University of Georgia Market Research Graduate Studies Pharmaceutical Business Information Research Group/European Pharmaceutical Market Research Association Drug Safety Alliance
Drug Information Association
Society of Competitive Intelligence
American Marketing Association
Marketing Research Association
Healthcare Businesswomen’s Association
*References Available upon Request
Contact this candidate